Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia

Blood

Volumn 120, Issue 26, 2012, Pages 5247-5249

  Churpek, Jane E ^a   Nickels, Eric ^a   Marquez, Rafael ^a   Rojek, Katarzyna ^a   Liu, Bohao ^a   Lorenz, Rachelle ^a   Lepore, Janet ^a   Madzo, Jozef ^a   Wickrema, Amittha ^a   Artz, Andrew S ^a   Van Besien, Koen ^a,b   Godley, Lucy A ^a  

^a SECTION OF HEMATOLOGY ONCOLOGY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; DISEASE PREDISPOSITION; DONOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HLA MATCHING; HUMAN; LETTER; LEUKEMIA CELL; MISSENSE MUTATION; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

EID: 84871605299     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-09-457945     Document Type: Letter

References (5)

1. Liew E, Owen C. Familial myelodysplastic syndromes: a review of the literature. Haematologica. 2011;96(10):1536-1542.
2. Fogarty PF, Yamaguchi H, Wiestner A, et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet. 2003;362(9396):1628-1630. (Pubitemid 37443532)
3. Mason PJ, Bessler M. The genetics of dyskeratosis congenita. Cancer Genet. 2011;204(12):635-645.
4. Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis. 2005;34(3):257-263. (Pubitemid 40693563)
5. Savage SA, Alter BP. Dyskeratosis congenita. Hematol Oncol Clin North Am. 2009;23(2):215-231.